ATI-001

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameATI-001

Drug Alias Nameavidimers (Avidimer)dendrimer-based anticancer agents (Avidimer)dendrimer-based folic acid/methotrexate covalent agents (Avidimer)ATI-001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDihydrofolate reductase inhibitorsFolic acid transporters modulators

TargetsDihydrofolate reductaseFolic acid transporters

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAvidimer Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAvidimer Therapeutics

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A